Skip to main content
TipRanks
Go Ultimate75% OFF

Mazen Darwazah Insider Profile

4 Followers

Mazen Darwazah, Vice Chairman & President at Hikma Pharmaceuticals, holds 8.97M shares in Hikma Pharmaceuticals (Ticker: GB:HIK).

Mazen Darwazah's Trading History

HIK
Hikma Pharmaceuticals
Jun 02, 2026Vice Chairman & President Uninformative Buy―£150.41M
GB:HIK
Insider Shares: 8.97M (417.53%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 02, 2026Uninformative Buy£0.0093,413£0.00――
Dec 19, 2025Informative Buy£1.50M100,000£1.50K+13.10%―
Nov 07, 2025Informative Buy£5.04M315,000£1.60K+9.10%―
Sep 17, 2025Informative Buy£224.42K14,000£1.60K+2.60%―
Aug 08, 2025Informative Buy£3.51M200,000£1.76K+0.60%―

You May Also Like

Mazen Darwazah insider profile FAQ

What is the percentage of profitable transactions made by Mazen Darwazah?
The percentage of profitable transactions made by Mazen Darwazah is 100%.
What is the average return per transaction made by Mazen Darwazah?
The average return per transaction made by Mazen Darwazah is 7.20%.
What stocks does Mazen Darwazah hold?
Mazen Darwazah holds: GB:HIK stocks.
What was Mazen Darwazah's most profitable transaction?
Mazen Darwazah’s most profitable transaction was an Informative Buy of GB:HIK stock on December 19, 2025. The return on the trade was 13.10%.
What is Mazen Darwazah's role in Hikma Pharmaceuticals?
Mazen Darwazah's role in Hikma Pharmaceuticals is Vice Chairman & President .
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.